Design and screening of a glial cell-specific, cell penetrating peptide for therapeutic applications in multiple sclerosis.
Multiple Sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system (CNS) characterized by demyelination through glial cell loss. Current and proposed therapeutic strategies to arrest demyelination and/or promote further remyelination include: (i) modulation of the host...
Enregistré dans:
Auteurs principaux: | Corey Heffernan, Huseyin Sumer, Gilles J Guillemin, Ursula Manuelpillai, Paul J Verma |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d80d25d58d49422cbb3b596d5b5de789 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome
par: Park CK, et autres
Publié: (2017) -
Synthetic molecular evolution of hybrid cell penetrating peptides
par: W. Berkeley Kauffman, et autres
Publié: (2018) -
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
par: Yu Han Liu, et autres
Publié: (2012) -
Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates
par: L. He, et autres
Publié: (2018) -
Synthesis and study of cell-penetrating peptide-modified gold nanoparticles
par: Boussoufi F, et autres
Publié: (2018)